Saliva test for glucose control
Phase 3
- Conditions
- Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications
- Registration Number
- CTRI/2022/09/046027
- Lead Sponsor
- Diabetes Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients attending diabetes clinic defined by their prior diagnosis and their antidiabetic usage
2. Subjects willing to be on Continuous Glucose Monitoring System for 14 days
Exclusion Criteria
Children,
pregnancy,
kidney disease,
liver disease or
any acute condition
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rapid (point-of-care) Saliva test (of Glycosylated Proteome), is a direct measure of 2-week glucose control in diabetes, as it is significantly associated with serum fructosamine, a known biomarker for 7-14 days diabetes control.Timepoint: at base line
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI